Pharmaceutical Manufacturing API Production Reactors
Roben Mfg, Inc. fabricates electro-polished pharmaceutical reactors specifically engineered for API production. Our cGMP-compliant vessels feature superior electro-polished surfaces that minimize contamination risk, facilitate cleaning validation, and support the stringent quality requirements of active pharmaceutical ingredient manufacturing.
Electro-Polished Reactors for API Production
API production demands the highest standards of cleanliness and surface quality. Our electro-polished pharmaceutical reactors provide the ultra-smooth surfaces essential for preventing product adhesion, ensuring complete cleanability, and maintaining batch-to-batch purity. These vessels support synthesis, crystallization, and isolation operations with the documentation and quality systems pharmaceutical manufacturers require.
Why Choose Pharmaceutical Manufacturing Electro-Polished Pharmaceutical Reactors from Roben Mfg?
- Superior electro-polished surfaces (≤15 Ra)
- cGMP-compliant design and fabrication
- Complete validation documentation
- ASME BPE compliance
- Minimized contamination risk
- Validated CIP/SIP capability
- Full material traceability
Key Features
- 316L stainless steel construction
- Electro-polished product contact surfaces
- Sanitary design principles
- Integrated CIP spray systems
- SIP-capable construction
- Orbital welded connections
- Complete documentation packages
Applications
- Small molecule API synthesis
- API crystallization and isolation
- Intermediate production
- Final API processing
- Purification operations
- Solvent handling
- Temperature-controlled reactions
- High-potency API production
Compliance and Certifications
Roben Mfg maintains comprehensive certifications ensuring our electro-polished pharmaceutical reactors meet the highest industry standards:
- ASME Section VIII Division 1 and Division 2 — “U” and “U2” Stamps
- ASME BPE (Bioprocessing Equipment) compliance
- National Board “R” Stamp for repairs and alterations
- ISO 9001:2015 Quality Management System
- PED (Pressure Equipment Directive) for European market
- FDA 21 CFR Part 11 ready documentation systems
Quality Assurance
Every electro-polished pharmaceutical reactor fabricated by Roben Mfg undergoes rigorous quality assurance protocols:
- Material certifications with complete traceability
- Qualified welding procedures and welders per ASME BPE
- Surface finish verification and documentation
- Orbital weld inspection and documentation
- Hydrostatic and pneumatic testing per ASME requirements
- Complete IQ/OQ documentation packages available
Frequently Asked Questions
1. What surface finish do your electro-polished reactors achieve?
Our electro-polished pharmaceutical reactors achieve surface finishes of ≤15 Ra (≤0.4 µm) on product contact surfaces, with options for ≤10 Ra for critical applications. Surface finish is verified by measurement and documented in quality records supporting validation requirements.
2. How does electro-polishing benefit API production?
Electro-polishing creates an ultra-smooth, passive surface that resists product adhesion, facilitates complete cleaning, and minimizes contamination risk. This supports cleaning validation, reduces cross-contamination potential, and ensures consistent product quality batch after batch.
3. What documentation do you provide for pharmaceutical validation?
We provide comprehensive documentation including material certifications with full traceability, weld maps and inspection records, surface finish verification reports, pressure test documentation, and fabrication procedures. Documentation packages support IQ/OQ protocols and regulatory submissions.
Contact Roben Mfg
Contact Roben Mfg today to discuss your pharmaceutical manufacturing API production reactors requirements. Our engineering team provides expert consultation on electro-polished reactor design, surface finish specifications, and complete pharmaceutical vessel solutions.
Phone: (281) 441-4088
Email: info@robenmfg.com
Website: www.robenmfg.com
